Prevention of Restenosis Following Revascularization

Vascular Disease, Peripheral Clinical Trial

Official title:
A Phase II Trial of ABI-007 (Paclitaxel Albumin-bound Particles) for the Prevention of Restenosis Following Revascularization of the Superficial Femoral Artery (SFA)

Status Terminated

Clinical Trial Summary

The purpose of this study is to investigate the prevention of Restenosis following Revascularization of the superficial Femoral Artery (SFA)

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00518284
Study type	Interventional
Source	Celgene
Contact
Status	Terminated
Phase	Phase 2
Start date	January 2008
Completion date	September 2009

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05783700` - Identification of Biomarkers for the Study of the Diabetic Foot and Evolution.
Completed	`NCT02135848` - 3 Month PHI PAD PoM Study	Phase 2
Recruiting	`NCT00542646` - Pilot Study to Evaluate the Safety and Preliminary Efficacy of the Peritec Peritoneal Lined Stent and Delivery System	Phase 0
Completed	`NCT05710653` - Inter-individual Physiological Response to a Training and Detraining Period in Cardiometabolic Risk Factors Subjects	N/A
Completed	`NCT04585763` - Disrupt PAD+ Study With the Shockwave Medical M5+ Peripheral IVL System	N/A
Not yet recruiting	`NCT05843929` - Prevalence of the Appearance of Diabetic Ulcers in Patients With 3D Insole and LSCI.	N/A
Recruiting	`NCT05860764` - Vascular Amputee Physical Performance Qualitative (VAmPP-Q) Study
Recruiting	`NCT05720156` - Immunomodulatory Effects of PCSK9 Inhibition
Completed	`NCT04146493` - Heparin-Binding Protein and Heparins